Total submissions: 26
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000131063 | SCV000185993 | benign | Hereditary cancer-predisposing syndrome | 2017-07-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000122238 | SCV000229772 | benign | not specified | 2016-12-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000122238 | SCV000243599 | benign | not specified | 2013-09-30 | criteria provided, single submitter | clinical testing | The variant is found in EPILEPSY,INFANT-EPI panel(s). |
Labcorp Genetics |
RCV000206029 | SCV000262487 | benign | Tuberous sclerosis 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000122238 | SCV000305224 | benign | not specified | 2018-02-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000042561 | SCV000395656 | likely benign | Tuberous sclerosis syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000122238 | SCV000540599 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ExAC: 0.9% (155/16504) South Asian chromosomes. ClinVar: 3 labs classify as benign/likely benign |
Center for Pediatric Genomic Medicine, |
RCV000034659 | SCV000609596 | benign | not provided | 2017-07-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000206029 | SCV000677549 | benign | Tuberous sclerosis 2 | 2017-05-25 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000206029 | SCV000782412 | uncertain significance | Tuberous sclerosis 2 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Institute for Genomic Medicine |
RCV000122238 | SCV000864295 | likely benign | not specified | 2017-07-17 | criteria provided, single submitter | clinical testing | BS1, BP6; This alteration has an allele frequency that is greater than expected for the associated disease, and was reported as a benign/likely benign alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory). |
ARUP Laboratories, |
RCV000034659 | SCV000884753 | benign | not provided | 2022-08-23 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000206029 | SCV001139760 | likely benign | Tuberous sclerosis 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000122238 | SCV002070009 | benign | not specified | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000131063 | SCV002533939 | benign | Hereditary cancer-predisposing syndrome | 2020-02-24 | criteria provided, single submitter | curation | |
Ce |
RCV000034659 | SCV002545718 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | TSC2: PM4:Supporting, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000122238 | SCV002598664 | likely benign | not specified | 2022-09-24 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000122238 | SCV002774075 | benign | not specified | 2022-02-07 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000206029 | SCV004016126 | benign | Tuberous sclerosis 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000206029 | SCV004360920 | benign | Tuberous sclerosis 2 | 2022-09-20 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034659 | SCV000043542 | probably not pathogenic | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Likely benign. |
Tuberous sclerosis database |
RCV000042561 | SCV000066355 | not provided | Tuberous sclerosis syndrome | 2011-04-06 | no assertion provided | curation | |
Tuberous sclerosis database |
RCV000042561 | SCV000066879 | not provided | Tuberous sclerosis syndrome | 2011-04-06 | no assertion provided | curation | |
ITMI | RCV000122238 | SCV000086461 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Genome Diagnostics Laboratory, |
RCV000034659 | SCV001808882 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000122238 | SCV001921709 | benign | not specified | no assertion criteria provided | clinical testing |